Physician

Ahmed F Abbas, MD

According to 2025 Medicare claims, Ahmed Abbas, MD (NPI: 1215420740) practices neurology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SIU PHYSICIANS & SURGEONS, INC (NPI: 1558385989; TIN: 36-4143823) and primary practice location at 62702-4968.

Abbas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 118 traditional Medicare patients, billed 2,151 HCPCS/CPT codes, and received $25,443 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 216 prescription claims across 44 beneficiaries totaling $524,530 in drug costs, led by Aubagio (Teriflunomide). Open Payments data shows 1 records totaling $100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $774 to $524,530. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$13K$25K2023 Medicare payment: $8,275 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $25,443 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20235594$8,275
20241182,151$25,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$262K$525K2019 Drug cost: $774 (USD; Tot_Drug_Cst)2020 Drug cost: $40,151 (USD; Tot_Drug_Cst)2021 Drug cost: $42,469 (USD; Tot_Drug_Cst)2022 Drug cost: $9,359 (USD; Tot_Drug_Cst)2023 Drug cost: $102,013 (USD; Tot_Drug_Cst)2024 Drug cost: $524,530 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192655$774
202030118$40,151
202136169$42,469
202237150$9,359
202335160$102,013
202444216$524,530

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1929$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3840$85
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2032$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2223$51

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AubagioTeriflunomide14420$131,640
LevetiracetamLevetiracetam21936$474
Amitriptyline HclAmitriptyline Hcl18540$323
BaclofenBaclofen11350$81
PrednisonePrednisone15418$46

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$100Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed F. Abbas, MD?

Tedicare shows public-source Medicare data for Ahmed F. Abbas, MD (NPI 1215420740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed F. Abbas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed F. Abbas, MD?

Ahmed F. Abbas, MD is linked to SIU PHYSICIANS & SURGEONS, INC (billing NPI 1558385989) in the available physician profile data.

Does Ahmed F. Abbas, MD have Open Payments data?

Ahmed F. Abbas, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.